about
The role of c-kit and imatinib mesylate in uveal melanoma.Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignanciesUveal Melanoma Patient-Derived XenograftsChinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Evidence for the Role of Blue Light in the Development of Uveal MelanomaChemosaturation Percutaneous Hepatic Perfusion: A Systematic ReviewHsp90 as a Potential Therapeutic Target in Retinal DiseaseTherapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumorsStudy design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT).Management of uveal melanoma: a consensus-based provincial clinical practice guidelineUveal melanoma in the peripheral choroid masquerading as chronic uveitisIn vivo high-frequency, contrast-enhanced ultrasonography of uveal melanoma in mice: imaging features and histopathologic correlations.Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors.Genetic predisposition to ocular melanoma.Inhibition of chemokine receptor expression on uveal melanomas by CXCR4 siRNA and its effect on uveal melanoma liver metastases.Risk factors for intraocular melanoma and occupational exposureUveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.Recurrence and massive extraocular extension of choroidal malignant melanoma after vitrectomy and endoresection.Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progressionA randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.The genetics of uveal melanoma: an emerging framework for targeted therapyOncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal MelanomaThe occurrence and proposed significance of Schnabel cavernous degeneration in uveal melanoma.Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation.Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis.Protein tyrosine phosphatase 4A3 (PTP4A3) is required for Xenopus laevis cranial neural crest migration in vivo.Genomic, prognostic, and cell-signaling advances in uveal melanoma.Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomasEye cancer incidence in Singapore.Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation.A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.Prevalence and characteristics of choroidal nevi: the multi-ethnic study of atherosclerosis.Mode of presentation and time to treatment of uveal melanoma in FinlandAssociation between choroidal pigmentation and posterior uveal melanoma in a white population.Association between posterior uveal melanoma and iris freckles, iris naevi, and choroidal naevi.PET/CT imaging: detection of choroidal melanoma.Orthotopic human choroidal melanoma xenografts in nude rats with aggressive and nonaggressive PAS staining patternsDistribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism.
P2860
Q21245647-BF5F80BF-AA15-4498-A9A1-29E20A83467FQ24644011-5248E270-5E9B-41A4-B825-6EAF79C7139DQ26750371-279527A1-D316-4B4A-94BC-E871FD062D5CQ26770492-0ED374FD-1E12-4534-AF00-B05EBD4FBFD2Q27006764-14205F7D-5BC7-4967-A860-899951AC6735Q28069495-4622E056-5B43-4C01-9DCF-B7752A653AABQ28083847-1ABBC54E-5320-48D3-AAA0-4B106835ADB7Q28482805-6364A4E2-EC33-42BB-A3D1-10FECD69CA3BQ30384829-76713C72-77E2-47A2-8D29-5D0256EFA611Q30388575-25639D9A-FF26-4180-A7F9-E84C12FC6697Q30428938-0ED3C21C-01C8-4F8E-9F9F-21798F9DC136Q30473934-6A36B45B-46A4-4322-A087-4EEBA3460836Q33442862-1F155309-716E-41D2-BA9E-AF8B5BAEDE9BQ33681811-139380EC-073D-47E8-8D88-2DA55BFD5D24Q33740330-1761CFB6-BE15-4E8E-849A-0A2BC73EAE71Q33741266-EC07BB05-9A45-4686-96B5-36732E1929EDQ33872396-D1859C51-954A-4C52-84D8-F87C572810D0Q34039169-492E739B-333A-4CA5-AF6B-9047AA97FB3AQ34135637-5760BD30-52B0-4C82-B3CB-514631341AE6Q34163690-07FF4F45-6288-4DD1-9850-30878D4202CEQ34249080-6742195B-812D-4403-99E8-0EF8AF2A7DE7Q34287626-32A80D1D-B6A8-4EED-94A9-80F21841BDDCQ34671160-6619E463-ECF9-4269-8375-FF3BC2805B91Q34754774-7C32ADB0-84D8-4372-BD48-0562C267D901Q34890998-09A86B94-C4A7-469E-9422-FAD784367866Q34918493-FA9247F3-39BA-4914-ABD1-D24E4232EF74Q35078466-1CD1BF14-8791-44DC-AB13-5D63F514C129Q35163192-D35CD88C-5170-4222-9C0A-2709362A4DFBQ35170650-8C6C3C81-0CE9-41B9-9666-65E4FD7E6382Q35311734-D45DE150-68ED-44E2-98CC-95708B6007D3Q35315339-3296D230-DD5A-4BDE-B821-4E8B2EB071C6Q35318290-85A36F11-096D-4BD4-917D-CC67776584EEQ35319993-32128E51-DC61-40D2-B6AD-B0FD7777000FQ35541801-882D372D-32EB-4977-9AAF-DE6B3D49F70EQ35589470-CBB25A47-A48E-44B2-AD8A-CC13A23C58D5Q35591580-02CCDF3C-CF3E-4C96-A596-A0F1A2836494Q35591678-D3423C81-7884-408A-BFEF-BE015CA3B74DQ35593779-C49CB17A-8B9B-43A4-B867-8ED518E61E01Q35762357-9B872690-3B79-458C-87B1-B0020C4A40ECQ35774475-173B4E93-3DE2-4EC9-9201-77734313CEAD
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Epidemiologic aspects of uveal melanoma.
@en
Epidemiologic aspects of uveal melanoma.
@nl
type
label
Epidemiologic aspects of uveal melanoma.
@en
Epidemiologic aspects of uveal melanoma.
@nl
prefLabel
Epidemiologic aspects of uveal melanoma.
@en
Epidemiologic aspects of uveal melanoma.
@nl
P2093
P1476
Epidemiologic aspects of uveal melanoma.
@en
P2093
P304
P356
10.1016/0039-6257(88)90173-7
P577
1988-01-01T00:00:00Z